These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18001410)

  • 1. Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum.
    Bister V; Mäkitalo L; Jeskanen L; Saarialho-Kere U
    J Cutan Pathol; 2007 Dec; 34(12):889-98. PubMed ID: 18001410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
    Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
    J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing.
    Salmela MT; Pender SL; Karjalainen-Lindsberg ML; Puolakkainen P; Macdonald TT; Saarialho-Kere U
    Scand J Gastroenterol; 2004 Nov; 39(11):1095-104. PubMed ID: 15545168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
    Impola U; Jeskanen L; Ravanti L; Syrjänen S; Baldursson B; Kähäri VM; Saarialho-Kere U
    Br J Dermatol; 2005 Apr; 152(4):720-6. PubMed ID: 15840104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease.
    Salmela MT; Karjalainen-Lindsberg ML; Jeskanen L; Saarialho-Kere U
    Mod Pathol; 2003 Feb; 16(2):108-14. PubMed ID: 12591962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
    Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
    J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.
    Vaalamo M; Karjalainen-Lindsberg ML; Puolakkainen P; Kere J; Saarialho-Kere U
    Am J Pathol; 1998 Apr; 152(4):1005-14. PubMed ID: 9546361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
    Cardillo MR; Di Silverio F; Gentile V
    Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
    Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
    J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of radiation-induced non-healing dermal wounds of the head and neck.
    Riedel F; Philipp K; Sadick H; Goessler U; Hörmann K; Verse T
    In Vivo; 2005; 19(2):343-50. PubMed ID: 15796196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer.
    Rayment EA; Upton Z; Shooter GK
    Br J Dermatol; 2008 May; 158(5):951-61. PubMed ID: 18284390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-inflammatory cytokine, matrix metalloproteinases and TIMP-1 are involved in wound healing after mastectomy in invasive breast cancer patients.
    Loo WT; Sasano H; Chow LW
    Biomed Pharmacother; 2007 Oct; 61(9):548-52. PubMed ID: 17904786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
    Nwomeh BC; Liang HX; Cohen IK; Yager DR
    J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis.
    Matsuno K; Adachi Y; Yamamoto H; Goto A; Arimura Y; Endo T; Itoh F; Imai K
    J Gastroenterol; 2003; 38(4):348-54. PubMed ID: 12743774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds.
    Vaalamo M; Weckroth M; Puolakkainen P; Kere J; Saarinen P; Lauharanta J; Saarialho-Kere UK
    Br J Dermatol; 1996 Jul; 135(1):52-9. PubMed ID: 8776359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].
    Klimiuk PA; Sierakowski S; Chwiećko J
    Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells.
    Ben-Hur T; Ben-Yosef Y; Mizrachi-Kol R; Ben-Menachem O; Miller A
    J Neuroimmunol; 2006 Jun; 175(1-2):12-8. PubMed ID: 16580738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.